Immunostimulatory DNA sequences inhibit respiratory syncytial viral load,airway inflammation, and mucus secretion

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 5, 2001, Pages 697-702

  Cho, Jae Youn ^a   Miller, Marina ^a   Baek, Kwang Je ^a   Castaneda, Diego ^a   Nayar, Jyothi ^a   Roman, Mark ^a   Raz, Eyal ^a   Broide, David H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Asthma; IFN ; Immunostimulatory DNA sequence; Respiratory syncyrial virus

Indexed keywords

CYTOKINE; DNA; GAMMA INTERFERON; METHACHOLINE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; IMMUNOSTIMULATION; LUNG LAVAGE; MOUSE; MUCUS SECRETION; NONHUMAN; PERIODIC ACID SCHIFF STAIN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFLAMMATION; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0035191613     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.119918     Document Type: Article

References (25)

1. Respiratory syncytial virus and parainfluenza virus
2. Respiratory syncytial vires bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7
3. Vires-induced airway hyperresponsiveness and asthma
4. Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness
5. Pathogenesis of RSV lower respiratory tract infection: Implications for vaccine development
6. Prospects for a respiratory syncytial virus vaccine
7. Interferon-γ expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenecity
8. Intranasal IFN-γ gene transfer protects Balb/c mice against respiratory syncytial virus infection
9. Immunostimulatory DNA sequences functions as T helper-1 promoting adjuvants
10. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin-6, interleukin 12 and interferon-γ
11. In vivo augmentation of natural killer cell activity and production of interferon-α/β and γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG
12. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperesponsiveness in mice
13. Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction
14. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease
15. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography
16. IL-13 induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent
17. Respiratory syncytial virus infection does not increase allergen induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice
18. Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
19. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12
20. Immune defence in mice lacking type I and/or type II interferon receptors
21. The function of type I interferons in antimicrobial immunity
22. Interferon-induced and double RNA-activated enzymes: A specific protein kinase and 2′. 5′-oligoadenylate synthetases
23. Imracellular murine IFN-γ mediates virus resistance, expression of oligoadenylate synthetase and activation of STAT transcription factors
24. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen
25. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice